Global Plasma Therapeutics Market 2015-2019

www.technavio.comenquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Global Plasma Therapeutics Market 2015-2019

The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Market Highlights

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on theGlobal Plasma Therapeutics

Market 2015-2019,please mail us at

enquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

Technavio’s Senior Analyst says, “Improving global economic conditions along with the provision of better healthcare infrastructure in developed countries has led to increased use of plasma therapeutics. Also, increased awareness about the potential uses of plasma therapeutics coupled with the increased demand for immunoglobulin therapies are factors that we believe will foster market growth.”

• Plasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other components that can be used for the treatment of various diseases.

• Technavio's analysts forecast the global plasma therapeutics market to grow at a CAGR of 12.10% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:

Global Plasma Therapeutics Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

USA – CANADA – UK – CHINA – INDIA

Vendors

To understand the vendor landscape and for a full list of

vendors view our report:

Global Plasma Therapeutics Market 2015-2019

Baxter International

CSL Behring

Grifols

Baxter International is a US-based healthcare company that develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

CSL Behring was established in 1904 and is headquartered in Pennsylvania, US. It is a subsidiary of CSL and is a global leader in the plasma protein biopharmaceutical industry.

Grifols was incorporated in 1940 and is headquartered in Barcelona, Spain. The company is a global biopharmaceutical company that is engaged in the R&D, manufacturing, and marketing of a wide range of drugs, pharmaceuticals, antibodies, bio-similar, and plasma derivative products worldwide, especially in Spain.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The global plasma therapeutics market is expected to grow at a rapid pace during the forecast period because of increased awareness about the potential uses of plasma therapeutics.

• Although there has been an increase in the global prevalence of rare conditions like hemophilia, von Willebrand disease, and immune deficiencies, effective treatment options for these diseases remain limited.

• Hence, the preference for plasma-derived proteins in the treatment of these diseases is increasing.

• This has led to an increase in research activities for the development of drugs using plasma proteins.

• Currently, various drugs and therapies are being developed for the treatment of diseases using plasma therapeutics, thereby leading to market growth.

USA – CANADA – UK – CHINA – INDIA

Key Market Highlights

• Authenticity • Delivery • Price• Service

Support

• Baxter, CSL Behring, Grifols Therapeutics, and Octapharma are the leading vendors in the global plasma therapeutics market.

• The market is growing at a very rapid pace because of the increased demand for plasma therapeutics, especially IVIG, in the treatment of rare diseases.

• This is in turn is leading to an increase in R&D.

• Companies like Abeona Therapeutics, ADMA Biologics, and Biotest Pharmaceuticals are expected to enter the market and attain significant market shares.

• Companies manufacturing and marketing plasma therapeutics that can effectively treat and cure life-threatening diseases, in addition to exhibiting a high safety and efficacy profile, are expected to gain a competitive edge over their peers.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?

Global Plasma Therapeutics Market 2015-2019

Let us identify your needs.We would love to hear more!

USA – CANADA – UK – CHINA – INDIA

Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

media@technavio.com

We’ll include an hour with our analysts to discuss the report findings.

For free.

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION